RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재 SCIE SCOPUS

    Thrombolytic Therapy during Cardiopulmonary Resuscitation in a Patient with Cardiac Arrest

    한글로보기

    https://www.riss.kr/link?id=A104688492

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Thrombolytic therapy during cardiopulmonary resuscitation is not routinely recommended, but 50-70% of cardiac arrests are caused by either acute myocardial infarction or masive pulmonary embolism. Thrombolytic therapy can be a reasonable treatment modality for a patient sufering with cardiac arest in an emergency situation and whose diagnosis is not known. We report here on a case with cardiac arrest and the diagnosis was not known. The patient was refractory to conventrional cardiopulmonary resuscitation, and he was treated with a bolus injection of (Korean Circ J 2007 ;37:663-665)
    번역하기

    Thrombolytic therapy during cardiopulmonary resuscitation is not routinely recommended, but 50-70% of cardiac arrests are caused by either acute myocardial infarction or masive pulmonary embolism. Thrombolytic therapy can be a reasonable treatment mod...

    Thrombolytic therapy during cardiopulmonary resuscitation is not routinely recommended, but 50-70% of cardiac arrests are caused by either acute myocardial infarction or masive pulmonary embolism. Thrombolytic therapy can be a reasonable treatment modality for a patient sufering with cardiac arest in an emergency situation and whose diagnosis is not known. We report here on a case with cardiac arrest and the diagnosis was not known. The patient was refractory to conventrional cardiopulmonary resuscitation, and he was treated with a bolus injection of (Korean Circ J 2007 ;37:663-665)

    더보기

    참고문헌 (Reference)

    1 Spohr F, "Thrombolytics in CPR:current advantages in cardiopulmonary resuscitation" 71 : 291-296, 2005

    2 Padosch SA, "Thrombolysis during cardio-pulmonary resuscitation" 51 : 516-532, 2002

    3 Bedel SE, "Survival after cardiopulmonary resuscitation in the hospital" 309 : 569-76, 1983

    4 Gurwitz JH, "Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction" 129 : 597-604, 1998

    5 Kilic E, "Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice" 10 : 107-111, 1999

    6 Robinson GR 2nd, "Postdischarge survival and func-tional status folowing in-hospital cardiopulmonary resuscitation" 105 : 991-6, 1994

    7 Kim YH, "Nonproteolytic neuroprotec-tion by human recombinant tissue plasminogen activator" 284 : 647-650, 1999

    8 Fischer M, "No-reflow after cardiac arest" 21 : 132-141, 1995

    9 Gando S, "Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest" 77 : 278-282, 1997

    10 Van de Werf F, "Management of acute myocardial infarction in patients presenting with ST segment elevation" 24 : 28-66, 2003

    1 Spohr F, "Thrombolytics in CPR:current advantages in cardiopulmonary resuscitation" 71 : 291-296, 2005

    2 Padosch SA, "Thrombolysis during cardio-pulmonary resuscitation" 51 : 516-532, 2002

    3 Bedel SE, "Survival after cardiopulmonary resuscitation in the hospital" 309 : 569-76, 1983

    4 Gurwitz JH, "Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction" 129 : 597-604, 1998

    5 Kilic E, "Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice" 10 : 107-111, 1999

    6 Robinson GR 2nd, "Postdischarge survival and func-tional status folowing in-hospital cardiopulmonary resuscitation" 105 : 991-6, 1994

    7 Kim YH, "Nonproteolytic neuroprotec-tion by human recombinant tissue plasminogen activator" 284 : 647-650, 1999

    8 Fischer M, "No-reflow after cardiac arest" 21 : 132-141, 1995

    9 Gando S, "Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest" 77 : 278-282, 1997

    10 Van de Werf F, "Management of acute myocardial infarction in patients presenting with ST segment elevation" 24 : 28-66, 2003

    11 An SH, "Factors influencing the survival of patients with prehospital cardiac arest" 31 : 1059-1065, 2001

    12 Newman DH, "Cardiac arrest and the role of thrombolytic agents" 35 : 472-480, 2000

    13 Antman EM, "ACC/AHA guide-lines for the management of patients with ST-elevation myocardial infarction-executive summary:a report of the American Colege of Cardiology/American Heart Association Task Force on Practice Guidelines" 110 : 588-636, 204

    14 Li X, "A meta-analysis of cardiopulmonary resuscitation with and without the administration of thrombolytic agents" 70 : 31-36, 2006

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
    2020-01-01 등재 등재학술지 유지 (해외등재 학술지 평가) KCI등재
    2011-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2009-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2008-05-15 학회명변경 한글명 : 대한순환기학회 -> 대한심장학회
    영문명 : The Korean Society Of Circulation -> The Korean Society of Cardiology
    KCI등재
    2007-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2005-08-02 학술지등록 한글명 : Korean Circulation Journal
    외국어명 : Korean Circulation Journal
    KCI등재
    2004-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    2003-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2001-07-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 1.13 0.34 0.71
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.45 0.36 0.52 0.12
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼